152 related articles for article (PubMed ID: 37528858)
1. Assessment of disease severity and patient prognosis in anti-GABA
Gao C; Chen Z; Huang H; Zhu R; Su Y
Front Neurol; 2023; 14():1201324. PubMed ID: 37528858
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary infection and baseline mRS scores predict poor prognosis in anti-GABA
Ding J; Xu D; Lv J; Wu T; Li J; Tian M; Lian Y
Front Immunol; 2022; 13():918064. PubMed ID: 36091075
[TBL] [Abstract][Full Text] [Related]
3. A Prognostic Analysis of the Outcomes in Patients With Anti-γ-Aminobutyric Acid B Receptor Encephalitis.
Chen W; Wang Y; Guo X; Gao L; Huang Z; Lin Y; Xue Q; Liu G; Zhang Y; Su Y
Front Immunol; 2022; 13():847494. PubMed ID: 35515002
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and prognosis of anti-γ-aminobutyric acid-B receptor encephalitis: A single-center, longitudinal study in China.
Feng X; Zhang Y; Gao Y; Zhang J; Yu S; Lv J; Zu Y; Wang L; Wang X
Front Neurol; 2022; 13():949843. PubMed ID: 36188394
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and prognosis of anti-GABABR encephalitis: A single-center experience.
Li Q; Zhang X; Zeng T; Yang B; Duan J; Tang Y
Medicine (Baltimore); 2023 Feb; 102(7):e32956. PubMed ID: 36800611
[TBL] [Abstract][Full Text] [Related]
6. Elevated cerebrospinal fluid YKL-40 levels in patients with anti-gamma-aminobutyric- acid-B receptor encephalitis.
Li J; Wang Y; Xia R; Zhao X; Li L; Wang S
J Neuroimmunol; 2023 Aug; 381():578119. PubMed ID: 37301084
[TBL] [Abstract][Full Text] [Related]
7. Case report: Pediatric anti-gamma aminobutyric acid-B receptor encephalitis with benign prognosis.
Wang Y; Ren X; Shen Y; Hua Y; Xu L; Zhang W; Sheng G; Jiang P; Yuan Z; Liu L; Gao F
Front Pediatr; 2023; 11():1104001. PubMed ID: 36937947
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and elevated ProGRP and positive oligoclonal bands of 13 Chinese cases with anti-GABABR encephalitis.
Wu H; Wang Y; Wei K; Qiao S; Liu L; Zhang R; Cao L; Wang S; Liu X
Int J Dev Neurosci; 2021 Oct; 81(6):492-501. PubMed ID: 33973258
[TBL] [Abstract][Full Text] [Related]
9. Typical clinical and imaging manifestations of encephalitis with anti-γ-aminobutyric acid B receptor antibodies: clinical experience and a literature review.
Si Z; Wang A; Liu J; Zhang Z; Hu K
Neurol Sci; 2019 Apr; 40(4):769-777. PubMed ID: 30671737
[TBL] [Abstract][Full Text] [Related]
10. The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies.
van Coevorden-Hameete MH; de Bruijn MAAM; de Graaff E; Bastiaansen DAEM; Schreurs MWJ; Demmers JAA; Ramberger M; Hulsenboom ESP; Nagtzaam MMP; Boukhrissi S; Veldink JH; Verschuuren JJGM; Hoogenraad CC; Sillevis Smitt PAE; Titulaer MJ
Brain; 2019 Jun; 142(6):1631-1643. PubMed ID: 31009048
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic challenge of small cell lung cancer with anti-gamma-aminobutyric-acid B receptor encephalitis: a case report.
Wang L; Yin J; Wang Q; Wang B; Song Y
Ann Transl Med; 2022 Dec; 10(24):1412. PubMed ID: 36660653
[TBL] [Abstract][Full Text] [Related]
12. SCLC and anti-GABABR encephalitis: A retrospective analysis of 60 cases in China.
Jiang C; Zhu M; Wei D; Duan H; Zhang Y; Feng X
Thorac Cancer; 2022 Mar; 13(6):804-810. PubMed ID: 35132785
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and long-term follow-up of seven cases of anti-GABABR encephalitis in patients of Han Chinese descent.
Zeng W; Cao L; Zheng J; Yu L
Neurol Sci; 2020 Feb; 41(2):373-378. PubMed ID: 31659584
[TBL] [Abstract][Full Text] [Related]
14. Encephalitis With Antibodies Against the GABA
Lin J; Li C; Li A; Liu X; Wang R; Chen C; Zhou D; Hong Z
Front Neurol; 2019; 10():1030. PubMed ID: 31681135
[No Abstract] [Full Text] [Related]
15. Diagnostic signatures and immune cell infiltration characteristics in anti-GABA
Qiao S; Zhang WY; Xie YF; Li HY; Cui CS; Tao SX; Xin T; Liu QJ
J Neuroimmunol; 2024 Mar; 388():578296. PubMed ID: 38309225
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Seizure and Antiepileptic Drug Utilization in Outpatients With Autoimmune Encephalitis.
Huang Q; Ma M; Wei X; Liao Y; Qi H; Wu Y; Wu Y
Front Neurol; 2018; 9():1136. PubMed ID: 30671012
[TBL] [Abstract][Full Text] [Related]
17. Cytokines/chemokines and soluble immune checkpoint molecules in anti-GABA
Qiao S; Xie Y; Li H; Zhang R; Wu Y; Liu X; Zhang S
Mult Scler Relat Disord; 2022 Dec; 68():104234. PubMed ID: 36270252
[TBL] [Abstract][Full Text] [Related]
18. The long-term outcome of neuropsychological function is favorable in patients with non-malignancy related anti-GABA
Ji C; Wu D; Chen Z; Wang K
BMC Neurol; 2021 Feb; 21(1):87. PubMed ID: 33622267
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Study of Patients with GABA
Wen X; Wang B; Wang C; Han C; Guo S
Neuropsychiatr Dis Treat; 2021; 17():99-110. PubMed ID: 33500619
[TBL] [Abstract][Full Text] [Related]
20. GABAB receptor autoantibody frequency in service serologic evaluation.
Jeffery OJ; Lennon VA; Pittock SJ; Gregory JK; Britton JW; McKeon A
Neurology; 2013 Sep; 81(10):882-7. PubMed ID: 23925760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
